- Home
- / Revelation Biosciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Revelation Biosciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.8
2024-10-29
Market Capitalization
$3.1 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|
| Cost of goods sold | 390.0K | |||||
| General and administrative expense | 145.5K | 3.1M | 5.5M | 4.5M | 4.4M | 5.0M |
| Operating expense total | 145.5K | 3.1M | 10.9M | 8.0M | 9.1M | |
| EBIT | (10.9M) | (8.7M) | (8.0M) | (9.1M) | ||
| Interest income | 9.3K | 222.0 | ||||
| Interest expense | 41.8K | |||||
| Pre tax profit | (136.4K) | |||||
| Net Income | (136.4K) | (2.1M) | (10.8M) | (120.3K) | (15.0M) | (8.9M) |
| EPS | (20.1) | (87.7) | (23.9) |